TP53 and Hepatic fibrosis: ART and artemether have been proven to trigger p53-dependent ferroptosis by promoting the accumulation of iron and lipid peroxides, which can inactivate hepatic stellate cells (HSCs) and ameliorate hepatic fibrosis (Wang L. et al., 2019; Kong et al., 2019).